hypertensive encephalopathy/калий

Линкът е запазен в клипборда

СтатииКлинични изследванияПатенти

Изберете тип сортиране

6 резултата

A case of Liddle's syndrome; unusual presentation with hypertensive encephalopathy.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Liddle's syndrome is a rare cause of secondary hypertension. Identification of this disorder is important because treatment differs from other forms of hypertension. We report an interesting case of a 35-year-old lady, a known diabetic and hypertensive patient, who presented with features of

Seizure and coma secondary to Conn's syndrome: a case report

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Background: Conn's syndrome is a curable condition if identified properly. It is characterized by autonomous secretion of aldosterone from the adrenal gland cortex. Its morbidity is related to the increased risk of cardiovascular

Licorice consumption as a cause of posterior reversible encephalopathy syndrome: a case report.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

BACKGROUND A 49-year-old woman was admitted to our hospital because of thunderclap headache and blurred vision. At the time of presentation, her blood pressure was 219/100 mmHg, her arterial pH was 7.64 and her potassium level was 2.7 mM/l. METHODS The combination of sequential computed tomography

[Treatment of anemia in hemodialysis patients using recombinant human erythropoietin: advantages and disadvantages].

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

18 anemic patients undergoing maintenance hemodialysis were treated with recombinant human erythropoietin (EPO) 1-3 times per week for 10.7 +/- 3 months. 4 patients underwent renal transplantation whereas 14 patients could be followed up during 12 months of EPO treatment. Hemoglobin concentration

Human recombinant erythropoietin in anaemic patients on maintenance haemodialysis. Secondary effects of the increase of haemoglobin.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Twelve anaemic patients on haemodialysis were treated with recombinant human erythropoietin, starting with 72 IU/kg/week. The dose was doubled after 2 weeks until an increase of 2 g/dl of haemoglobin was observed. The effects on various parameters were studied during a 3-month period. Haemoglobin

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

OBJECTIVE To determine the effectiveness and safety of recombinant human erythropoietin (rHuEpo). METHODS Hemodialysis patients (333) with uncomplicated anemia (hematocrit less than 0.30). All received rHuEpo intravenously, three times per week at 300 or 150 U/kg body weight, which was then reduced

Присъединете се към нашата
страница във facebook

Herbal & Natural Medicine

Най-пълната база данни за лечебни билки, подкрепена от науката

Работи на 55 езика
Билкови лекове, подкрепени от науката
Разпознаване на билки по изображение
Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
Прочетете научни публикации, свързани с вашето търсене
Търсете лечебни билки по техните ефекти
Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания